Phase II, Open-Label Trial to Assess the Activity of ZD1839 (IRESSA TM) in Patients With Recurrent Prostate Cancer Who Have Rising Serum PSA Levels Despite Serum Testosterone < 50mg/dl
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006151/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
A study to assess the activity of Iressa in patients who's prostate cancer has recurred, and who have rising PSA levels
提供机构：
Vivli
创建时间：
2020-10-30
